...
首页> 外文期刊>Bioinformatics >Semi-supervised recursively partitioned mixture models for identifying cancer subtypes
【24h】

Semi-supervised recursively partitioned mixture models for identifying cancer subtypes

机译:半监督递归分区混合模型,用于识别癌症亚型

获取原文
获取原文并翻译 | 示例
           

摘要

Motivation: Patients with identical cancer diagnoses often progress differently. The disparity we see in disease progression and treatment response can be attributed to the idea that two histologically similar cancers may be completely different diseases on the molecular level. Methods for identifying cancer subtypes associated with patient survival have the capacity to be powerful instruments for understanding the biochemical processes that underlie disease progression as well as providing an initial step toward more personalized therapy for cancer patients. We propose a method called semi-supervised recursively partitioned mixture models (SS-RPMM) that utilizes array-based genetic and patient-level clinical data for finding cancer subtypes that are associated with patient survival.Results: In the proposed SS-RPMM, cancer subtypes are identified using a selected subset of genes that are associated with survival time. Since survival information is used in the gene selection step, this method is semi-supervised. Unlike other semi-supervised clustering classification methods, SS-RPMM does not require specification of the number of cancer subtypes, which is often unknown. In a simulation study, our proposed method compared favorably with other competing semi-supervised methods, including: semi-supervised clustering and supervised principal components analysis. Furthermore, an analysis of mesothelioma cancer data using SS-RPMM, revealed at least two distinct methylation profiles that are informative for survival.
机译:动机:患有相同癌症的患者通常会有所不同。我们在疾病进展和治疗反应方面看到的差异可以归因于这样的想法,即两种组织学相似的癌症在分子水平上可能是完全不同的疾病。识别与患者生存相关的癌症亚型的方法有能力成为了解疾病进程基础的生化过程以及为癌症患者提供更个性化治疗的第一步的强大工具。我们提出一种称为半监督递归分区混合模型(SS-RPMM)的方法,该方法利用基于阵列的遗传和患者水平的临床数据来发现与患者生存相关的癌症亚型。结果:在拟议的SS-RPMM中,癌症使用与存活时间相关的选定基因子集来鉴定亚型。由于在基因选择步骤中使用了生存信息,因此该方法是半监督的。与其他半监督聚类分类方法不同,SS-RPMM不需要指定癌症亚型的数量,这通常是未知的。在仿真研究中,我们提出的方法与其他竞争性半监督方法相比具有优势,其中包括:半监督聚类和监督主成分分析。此外,使用SS-RPMM对间皮瘤癌症数据进行分析后发现,至少有两个不同的甲基化谱对生存具有指导意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号